Condition: Lung Diseases, Interstitial · Sponsor: R-Pharm International, LLC
The purpose of this study is to evaluate efficacy and safety of olokizumab (OKZ) compared to placebo in patients progressive fibrosing Interstitial lung diseases (ILD).
This description comes directly from the study's public registry record.
Yana Deloveri · + 7 (968) 585-13-49 · deloveri@rpharm.ru
Maria Lemak · +7 (903) 709-20-43 · lemak@rpharm.ru
Always discuss trial participation with your own doctor first.
| Regional Clinical Hospital Regional state budgetary healthcare institution | Barnaul, Russia | Recruiting |
| Regional Clinic Hospital№3 | Chelyabinsk, Russia | Recruiting |
| Chelyabinsk Regional Clinical Hospital | Chelyabinsk, Russia | Recruiting |
| State budgetary healthcare institution of the Leningrad region "Gatchina Clinical Interdistrict Hospital" | Gatchina, Russia | Recruiting |
| LLC" Medsi-Izhevsk" | Izhevsk, Russia | Recruiting |
| LLC "Scientific Research Medical Complex "Your Health" | Kazan', Russia | Recruiting |
| Kuzbass Clinical Hospital Emergency Medical Care named after Podgorbunsky M.A | Kemerovo, Russia | Recruiting |
| State Budgetary Healthcare Institution Research Institute-Karpaty Clinical Hospital No. 1 named after prof. S.V. Ochapovsky | Krasnodar, Russia | Recruiting |
| City Clinical Hospital named after Davydovsky I.V. | Moscow, Russia | Recruiting |
| GBUZ Moscow Clinical Scientific Center named after Loginov MHD | Moscow, Russia | Recruiting |
| Scientific Research Institute of Reumatology named after Nasonova V.A | Moscow, Russia | Recruiting |
| Moscow City Polyclinic №52 | Moscow, Russia | Recruiting |
+ 21 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06440746